David A. Lieberman, MD, discussed colonoscopy and how alternatives are a work in progress at the summit. Alternatives, such as fecal immunochemical testing and stool DNA testing exist, but these tests have yet to be perfected.
Dr. Lieberman also discussed the possibility of using serum testing to risk stratify patients, as well as the role pill camera endoscopy has to play.
More articles on gastroenterology:
5 most read GI stories – April 6 to April 10
IBD risk reaches to third degree relatives
Cologuard receives coverage from 5 commercial health plans
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
